BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Policy

  FDA Indicates That Jaguar’s Canalevia Drug Product Candidate Qualifies As “Minor Use” For Exercise-Induced Diarrhea (EID) In Dogs, Rendering Canalevia Eligible For Conditional Approval For This Indication

  September 20, 2017

   · 

  9 min read
• BioCapital

  The Emmes Corporation Sponsors Leadership Montgomery’s Corporate Volunteer Council

  September 20, 2017

   · 

  3 min read
• Business

  West Australian Neurologist Appointed President Of The World Federation Of Neurology

  September 20, 2017

   · 

  3 min read
• Drug Development

  Bone Therapeutics: Announces All Patients Meet Primary Endpoint In ALLOB Phase I/IIA Delayed-Union Study Interim Analysis

  September 20, 2017

   · 

  7 min read
• Emerald Health Therapeutics’ Scientific Advisors Publish Research Discovery Of THCA Cannabinoid’s Neuroprotective Treatment Potential

  September 20, 2017

   · 

  5 min read
• Business

  Bay Area’s Relievant Medsystems Names a New CEO

  September 20, 2017

   · 

  3 min read
• Business

  Spark Therapeutics Enters Into Licensing Agreement With Genethon

  September 20, 2017

   · 

  4 min read
• BioMidwest

  KemPharm Files IND For KP484 For The Treatment Of ADHD, An Investigational Prodrug Of Methylphenidate

  September 20, 2017

   · 

  5 min read
• Merus’ Intellectual Property Portfolio Expands With Two New Patents For Its Biclonics Technology

  September 20, 2017

   · 

  6 min read
• Deals

  Krystal Biotech Announces Pricing Of Upsized Initial Public Offering

  September 20, 2017

   · 

  2 min read